Chorionic Villi Sampling among Early and Late Gestational Age: Does Timing Affect Yield and Outcomes?

Read full text Summarise with VIRAT
Authors: Julia Kim, Amberly Lao, Annie Rozenblyum, Lamia A. Alamri, Abigail Ludwigson, Teresa Dunn, Andrei Rebarber, Jennifer Lam‐Rachlin, Manesha Putra, Martin R. Chavez, Patricia Rekawek, Lakha Prasannan
Cited by: 0
References: 16

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: weeks to detect genetic abnormalities; however, a majority of providers opt to perform CVS after 11 weeks. This study evaluated the feasibility of CVS performed at varying gestational ages, comparing chorionic villi (CV) yield and procedural outcomes among early, typical, and late procedures. Materials and Methods: weeks). The primary outcome was median CV weight. Secondary outcomes included need for culture, time to microarray results, and a subanalysis of abnormal chromosomal microarray analysis (CMA) results, obstetric, and neonatal outcomes. Results: Of 719 patients, 8.1% underwent early, 83.2% typical, and 8.8% late CVS. The early cohort had a lower body mass index (BMI). Early CVS was most frequently performed transvaginally and for the indication of prior affected pregnancy, and less likely for abnormal genetic screening or ultrasound findings. Median villi weight did not differ significantly, and 89% of all procedures yielded adequate tissue, defined as ≥5 mg. The time to the microarray result was shortest in the typical group. There were no significant differences in other secondary outcomes of need for culture, number of passes, or procedure-related complication rates. There was no case of limb anomalies. Conclusion: CVS performed before 11 weeks and after 14 weeks demonstrated comparable microarray outcomes and demonstrate the technical feasibility and diagnostic adequacy of CVS performed outside the typical gestational window. The results also support the availability of early CVS for cytogenetic testing in early pregnancy loss, where management may not allow for direct tissue testing. Prospective studies are warranted to validate these results and refine recommendations for optimal timing of CVS.

Fields of Study & Subjects

Prenatal Screening and Diagnostics Genomics and Rare Diseases Preterm Birth and Chorioamnionitis

Publication details

Journal / source
American Journal of Perinatology Reports
Volume
16
Issue
02
Pages
e77–e82
Publication date
25 March 2026
Language
EN